Planmeca Viso® G3 now available – Enter a new dimension

The wait is over – Planmeca Viso® G3 is here. As the newest member of the Planmeca Viso® family of world-class imaging units, Planmeca Viso G3 offers innovative features, fantastic usability, and outstanding image quality for a cutting-edge CBCT imaging experience. Now available for deliveries.

 

Planmeca Viso® G3 is the newest member of the popular Planmeca Viso® family of CBCT units, which are the choice imaging units of dental professionals around the world. It is a truly multifunctional CBCT device, covering all extraoral imaging needs from 2D to 3D imaging. Complemented by the all-in-one Planmeca Romexis® dental software, the new unit completes Planmeca’s line of next-generation CBCT units alongside Planmeca Viso® G7 and Planmeca Viso® G5.

Industry-leading usability and visibility

Planmeca Viso G3 brings industry-leading usability and visibility for an even wider range of clinics and clinical needs, from endodontics to implantology. With a Field of View (FOV) ranging from 3 x 3 to 20 x 10 cm, the unit not only offers high-quality 3D images of the entire dentition, but is able to capture detailed panoramic as well as extraoral bitewing images for interproximal diagnostics. Additionally, the unit can be equipped with the Planmeca ProCeph™ one-shot cephalostat and, when the time is right, upgraded to Planmeca Viso G5 for a larger maximum 3D volume.

The new imaging unit also comes with all the benefits of Planmeca’s tried-and-true Viso technology. This includes easy-to-use imaging programs, a live video view for successful patient positioning and virtual FOV adjustments, freely adjustable 3D volume size and anatomical target selection. Additionally, the completely redesigned user interface can be mirrored on the workstation, reducing the need to move back and forth between the workstation and the patient.

More tools for less exposure

In line with the ALADA (As Low As Diagnostically Acceptable) principle, Planmeca Viso G3 also comes with multiple advanced ways of reducing patient doses. These include the scientifically proven Planmeca Ultra Low Dose™ protocol, which reduces the effective patient dose without a statistical reduction in image quality. Additionally, scout images can be used to fine-tune the 3D volume before acquisition, while the unique Planmeca CALM® algorithm for motion artifact correction can be applied both before and after acquisition to reduce the need for retakes, especially when imaging livelier patients.

Combined, these features come together for a smooth and speedy imaging workflow that is truly exceptional – without compromising safety or patient comfort.

CEVAP VER

Please enter your comment!
Please enter your name here